No Data
No Data
H.C. Wainwright Maintains Genmab(GMAB.US) With Buy Rating, Maintains Target Price $50
HC Wainwright & Co. Maintains Buy on Genmab, Maintains $50 Price Target
Genmab Analyst Ratings
TD Cowen Maintains Genmab(GMAB.US) With Hold Rating
TD Cowen Sticks to Their Hold Rating for Genmab (GMAB)
Danish Stocks Mixed as Trump Threatens Tariffs to Acquire Greenland